D.C. Analysis: Trump’s method to well being care, Sarepta’s lobbyists
You’re studying the net version of D.C. Analysis, STAT’s twice-weekly e-newsletter in regards to the politics and coverage of well being and drugs. Enroll right here to obtain it in your inbox on Tuesdays and Thursdays.
I used to be reminded just lately of why I dig mass transit upon overhearing the practice conductor and two middle-aged males engaged in a critical discuss mattresses, “trash” 400-thread-counts, and the professionals and cons of weighted sheets. Ship me your ideas for an opulent night time’s sleep, and information tricks to [email protected] or John_Wilkerson.07 on Sign.
It’s who you recognize that issues
Sarepta Therapeutics, which has come underneath regulatory strain over its gene remedy for Duchenne muscular dystrophy, employed the Trump-connected lobbying agency Michael Finest Methods after the demise of a teenage boy handled with the drug, in keeping with lobbying disclosure reviews.
This text is unique to STAT+ subscribers
Unlock this text — plus in-depth evaluation, newsletters, premium occasions, and information alerts.
Have already got an account? Log in
To learn the remainder of this story subscribe to STAT+.
